Ariana Grande Performs at 10th Annual Delete Blood Cancer Gala  

International superstar Ariana Grande will perform at the 10th Annual DKMS Gala, taking place Thursday, May 5 at Cipriani Wall Street. DKMS also announced that the benefit gala will honor Angelina & Monte Lipman and Daniele & Alexandre Behring for their continued support and dedication to help delete blood cancer. The event will raise funds for the largest bone marrow donor center in the world.
�
Dr. Angelina Lipman and Monte Lipman are pillars of the New York philanthropic community. Not only are they integral to the heartbeat of DKMS, but they also remain active for other great causes and serve on the board of TJ Martell Foundation, Amy Winehouse Foundation, and recently honored by UJA-Federation of New York. �

Dr. Lipman's experience includes serving as Professor at the Business School of Columbia University while also working in the corporate sector. Her forthcoming literary debut, "Blocking The Noise," is scheduled for release later this year. Mr. Lipman is the co-founder and chief executive of Republic Records -- the music industry's #1 label for four consecutive years according Nielsen's Soundscan.
�
Alex Behring is a co-founder and the Managing Partner of 3G Capital, a global investment firm. Behring serves as Chairman of Restaurant Brands International since December 2014, following 3G Capital's acquisition of Burger King in October 2010 and subsequent combination with Tim Hortons in December 2014.

Mr. Behring also serves as Chairman of the Kraft Heinz Company since July 2015, following Berkshire Hathaway and 3G Capital's acquisition H.J. Heinz Company in June 2013 and subsequent combination with Kraft Foods Group in July 2015.� He also serves as a Director of Anheuser-Busch Inbev since April 2014. Daniele Giacomazzi Behring is an untiring advocate of the children's health cause.

Behring worked in corporate marketing and human resources, and complemented her studies at Tavistock Institute London. In 2011, her ties with Brazil put her in contact with the work developed by Hospital Pequeno Pr�ncipe -- the biggest pediatrician Hospital in Brazil�and the Pel� Little Prince�Research Institute since then, she has been working to engage Corporations and individuals to the cause. The Behrings work to help individuals and corporations become supporters that help in the advance of many of the institution's projects related to Health as DKMS.
�

"We are so thrilled to have the support of Ariana and can't wait to see her performance!" stated DKMS co-founder Katharina Harf. "The efforts and support of the Lipmans and Behrings over the years also make them overdue for the recognition they deserve. We're so pleased both families could be with us this year so DKMS could give them the appreciation they deserve."

GRAMMY� Award-nominated multiplatinum superstar Ariana Grande stands out as one of pop's most powerful voices and influential modern icons. She consecutively released two platinum-certified #1 albums on the Billboard Top 200, garnered two GRAMMY� Award nominations, broke many chart records, covered numerous magazines, performed and hosted on "Saturday Night Live," and sold out shows all around the world. Her third full-length album, "Dangerous Woman," releases May 20 as her influence continues to expand.

This year also marks the 25th anniversary of DKMS, whose mission is to continually increase the number of suitable bone marrow donors. This year's Corporate Founding Sponsor is COTY Inc. and COTY Global Ambassador Georgia May Jagger. Event Honorary Chair members include interim CEO of COTY Inc., Bart Becht, EVP & CFO of COTY Inc., Patrice de Talhouet, and Delete Blood Cancer DKMS Co-Founder Katharina Harf. Katharina and her father, Peter Harf, founded DKMS in honor of their mother and wife, Mechtild Harf. Carina Ortel is the Delete Blood Cancer DKMS Chief Executive Officer.

Delete Blood Cancer DKMS US is part of the international DKMS Group of donor centers. Our mission is to build the number of suitable bone marrow donors, because we believe that no life should be lost due to an inability to find a donor match. We have registered more than 6 million potential donors and helped to facilitate more than 54,000 transplants around the world. But we're not stopping there. We lead the fight against blood cancer by working with families, communities and organizations to recruit donors and provide more patience with second changes at life.